Neuromedin U drives immune suppression in aggressive prostate cancer
A new study from The Wistar Institute has found a link between the nervous system and the rapid…
Targeting metabolic pathways could prevent relapse in KRAS-mutant cancers
Our cells rely on tightly regulated signaling pathways to control when they grow, divide, and survive. When these…
New drug combination shows promise in treating colorectal cancer
Colorectal cancer is one of the most common tumors among people over the age of 50. Although it…